C3 and age-related macular degeneration: AMD is a prevalent OD driven by a complement, and C3 is the central complement component and a key inflammatory protein activated in AMD [24]; the drugs related to C3, such as compstatin and pegcetacoplan, are used for the treatment of AMD [25,26].